Annual revenue rose from KRW 140.2 billion in 2022 to KRW 223.6 billion in 2023 (up 59.5% year on year), fell to KRW 184.9 billion in 2024 (down 17.3%), and recovered to KRW 236 billion in 2025 (up 27.7%), the largest of the 2022 to 2025 years.
Operating profit was KRW 10.3 billion in 2022 and KRW 21.2 billion in 2023 (up 105.6%). In 2024 the company posted an operating loss of KRW 732 million, a swing to loss from the prior year, and in 2025 it returned to operating profit of KRW 32.3 billion, a turnaround to profit.
The operating margin moved from 7.4% in 2022 to 9.5% in 2023, -0.4% in 2024 and 13.7% in 2025. Profit attributable to controlling shareholders was KRW 11.6 billion in 2022, KRW 21.5 billion in 2023 (up 85.1%), KRW 1.19 billion in 2024 (down 94.5%) and KRW 22.4 billion in 2025 (up 1,786.2%).
Net income including non-controlling interests is a different figure, and the 2024 gap between KRW 2 billion of net income and KRW 1.19 billion of controlling-shareholder profit reflects that difference.
Operating cash flow was KRW 15.2 billion, KRW 18.8 billion, KRW 9.84 billion and KRW 27.4 billion for 2022 through 2025. At the end of 2025, total equity was KRW 193.7 billion, of which controlling-shareholder equity was KRW 188.6 billion, and total liabilities were KRW 78.9 billion.
The debt ratio was 51.4% in 2022, 35.1% in 2023, 40.5% in 2024 and 40.7% in 2025. Quarterly revenue was KRW 69.9 billion in Q3 2025 and fell 15.8% quarter on quarter to KRW 58.8 billion in Q4 2025, when operating profit fell 61.9% to KRW 5.36 billion.
Revenue then reached KRW 62.1 billion in Q2 2026 (up 16.2% quarter on quarter), but operating profit was KRW 4.76 billion, down 9.7%.
In Q3 2026 revenue was KRW 63.9 billion (up 2.9% quarter on quarter, down 8.5% year on year) while operating profit was KRW 3.68 billion (down 22.7% quarter on quarter, down 73.8% year on year).
Controlling-shareholder profit was KRW 10 billion in Q3 2025, KRW 1.65 billion in Q4 2025, KRW 6.62 billion in Q1 2026, KRW 1.95 billion in Q2 2026 and KRW 2.85 billion in Q3 2026, totaling KRW 13.1 billion over the last four quarters. Revenue gains in 2026 have not carried through to operating profit.
The company attributed the 2025 growth mainly to MD sales linked to the BLACKPINK world tour (Newspim, reported February 26, 2026).